We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Delaying Appendicitis Treatment Could Lead to Death

By HospiMedica International staff writers
Posted on 31 Oct 2011
Delaying treatment for appendicitis beyond two days after children were admitted to a hospital led to more complications, higher health care costs, and even death, according to a new study.

Researchers from St. More...
Elizabeth Medical Center (Boston, MA, USA) identified 683,016 patients from the US National Inpatient Sample (aged 18 or younger), who suffered from appendicitis between 2000 and 2008. In 17,737 of those children (2.6%), surgery was performed on in-hospital day two or later, with a mean interval from hospitalization to appendectomy of 4.5 days. These children had a 22.6% incidence rate of perforated appendicitis, compared to 18.9% in those children receiving more immediate treatment. The delayed treatment group also had a 20-fold increase in mortality, leaping from 0.03% to 0.68%.

The results also showed that delayed treatment was associated with a 13-fold increase in drainage procedures, a six-fold increase in cecectomies, an 11-fold increase in small bowel lacerations, a 15-fold increase in small bowel resections, and a 14-fold increase in hemicolectomies. Additionally, mean hospital stay was more than 10 days for the delayed treatment group versus only 2.89 days for promptly treated children. On multivariate analysis, a delay in treatment was predicted by acute lymphoid leukemia, acute myeloid leukemia, neutropenia, and ovarian cyst without torsion. The study was presented at the annual American Academy of Pediatrics (AAP) national conference and exhibition, held during October 2011 in Boston (MA, USA).

“If surgery is done within 24 hours, there is no relationship between time to procedure and outcome,” said lead author and study presenter Justin Lee, MD. “The 48-hour time period may be a clinically important time period in which uncomplicated appendicitis can become complicated appendicitis with peritonitis, rupture, or periappendiceal abscess.”

Appendicitis is a condition characterized by inflammation of the appendix. It is classified as a medical emergency and many cases require removal of the inflamed appendix, either by laparotomy or laparoscopy. Appendicitis has been recognized as one of the most common causes of severe acute abdominal pain worldwide; untreated, mortality is high, mainly because of the risk of rupture leading to peritonitis and shock.

Related Links:

St. Elizabeth Medical Center





Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.